HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad Imtiaz Hasan Selected Research

Insulin Detemir (Levemir)

12/2013Safety and effectiveness of biphasic insulin aspart 30 in different age-groups: a1chieve sub-analysis.
11/2013Biphasic insulin aspart 30 in insulin-naive people with type 2 diabetes in non-western nations: results from a regional comparative multinational observational study (A(1)chieve).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad Imtiaz Hasan Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
11/2014 - 11/2013
1Weight Gain
11/2014
1Hypoglycemia (Reactive Hypoglycemia)
12/2013

Drug/Important Bio-Agent (IBA)

2Insulin Detemir (Levemir)FDA Link
12/2013 - 11/2013
2insulin aspart protamine drug combination 30:70 insulin aspartIBA
12/2013 - 11/2013
2Insulin (Novolin)FDA Link
12/2013 - 11/2013
2Insulin Aspart (NovoLog)FDA Link
12/2013 - 11/2013
1VildagliptinIBA
11/2014

Therapy/Procedure

1Therapeutics
12/2013
1Glycemic Control
12/2013